Transplantation of a kidney with a heterozygous mutation in the SLC22A12 (URAT1) gene causing renal hypouricemia: a case report.

BMC Nephrology
Kiyokazu TsujiTomoya Nishino

Abstract

Renal hypouricemia (RHUC) is a genetic disorder caused by mutations in the SLC22A12 gene, which encodes the major uric acid (UA) transporter, URAT1. The clinical course of related, living donor-derived RHUC in patients undergoing kidney transplantation is poorly understood. Here, we report a case of kidney transplantation from a living relative who had an SLC22A12 mutation. After the transplantation, the recipient's fractional excretion of UA (FEUA) decreased, and chimeric tubular epithelium was observed. A 40-year-old man underwent kidney transplantation. His sister was the kidney donor. Three weeks after the transplantation, he had low serum-UA, 148.7 μmol/L, and elevated FEUA, 20.8% (normal: < 10%). The patient's sister had low serum-UA (101.1 μmol/L) and high FEUA (15.8%) before transplant. Suspecting RHUC, we performed next-generation sequencing on a gene panel containing RHUC-associated genes. A heterozygous missense mutation in the SLC22A12 gene was detected in the donor, but not in the recipient. The recipient's serum-UA level increased from 148.7 μmol/L to 231.9 μmol/L 3 months after transplantation and was 226.0 μmol/L 1 year after transplantation. His FEUA decreased from 20.8 to 11.7% 3 months after transplantation a...Continue Reading

References

Jan 1, 1992·Contributions to Nephrology·O Sperling
Mar 1, 1989·Klinische Wochenschrift·C M ErleyK Schaefer
Sep 1, 1972·The American Journal of Medicine·M L GreeneJ E Seegmiller
Jun 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J Y Yeun, J A Hasbargen
Dec 25, 2003·Journal of the American Society of Nephrology : JASN·Kimiyoshi IchidaTatsuo Hosoya
Jan 30, 2004·Journal of the American Society of Nephrology : JASN·Makoto HosoyamadaHitoshi Endou
May 20, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Toshiyuki OhtaUNKNOWN ARF Assocoated with Renal Hypouricemia Research Group
Aug 26, 2004·Kidney International·Naoharu IwaiHitoshi Endou
Feb 2, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Izumi YamamotoTatsuo Hosoya
Apr 21, 2007·Pediatrics International : Official Journal of the Japan Pediatric Society·Yasufumi OhtsukaYuhei Hamasaki
Dec 15, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Dganit DinourEliezer J Holtzman
Dec 24, 2011·PloS One·Velibor TasicJohn A Sayer
Jan 20, 2012·Clinical Nephrology·Naoto NishizakiKazunari Kaneko
Oct 11, 2013·American Journal of Nephrology·Hiroshi KaitoKazumoto Iijima
Mar 6, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Shinobu SugiharaKazuhiro Yamamoto
Mar 6, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Sue RichardsUNKNOWN ACMG Laboratory Quality Assurance Committee

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.